Chief Financial Officer
Most recently, Mr. McNulty served as Senior Director of Business Development at Repligen Corporation, where his responsibilities included out-licensing programs for rare neurodegenerative diseases. Previously, he was Director of Corporate Development at Seventh Sense Biosystems and Associate Director of Business Development and Alliance Management at Genzyme Corporation. While at Genzyme, he led business development activities in the area of neurology. Before joining Genzyme, Mr. McNulty held technical roles at Transform Pharmaceuticals and Cereon Genomics. He has an MBA from Harvard Business School, and BS and MEng degrees from MIT, where he performed research on biological hydrogels.